Ligand validation:5FF1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5FF1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FF1_NAG_A_603	85%	20%	0.09	0.954	1.32	2.02	1	6	0	0	100%	0.9333
5FF1_NAG_A_606	80%	27%	0.096	0.944	0.92	2.01	1	2	0	0	100%	0.9333
5FF1_NAG_B_603	76%	39%	0.097	0.932	0.69	1.65	-	5	0	0	100%	0.9333
5FF1_NAG_B_602	50%	18%	0.128	0.876	1.08	2.42	1	5	0	0	100%	0.9333
5FF1_NAG_A_604	39%	26%	0.167	0.874	0.75	2.19	-	8	0	0	100%	0.9333
5FF1_NAG_B_604	20%	41%	0.169	0.769	0.52	1.73	-	1	0	0	100%	0.9333
5FF1_NAG_A_605	15%	23%	0.176	0.734	0.65	2.47	-	6	0	0	100%	0.9333
8Y9X_NAG_A_629	87%	61%	0.088	0.961	0.41	1.05	-	-	4	0	100%	0.9333
6LQW_NAG_A_607	81%	60%	0.104	0.957	0.55	0.96	-	1	0	0	100%	0.9333
8ING_NAG_A_602	75%	55%	0.103	0.937	0.71	1.01	-	-	1	0	100%	0.9333
7Y3U_NAG_A_605	72%	30%	0.125	0.95	0.71	2.06	-	3	0	0	100%	0.9333
6L2J_NAG_A_603	72%	43%	0.097	0.92	0.6	1.57	-	3	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_B_501	100%	68%	0.024	0.991	0.38	0.86	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.